INGRAM ROBERT ALEXANDER 4
4 · Black Diamond Therapeutics, Inc. · Filed Sep 19, 2022
Insider Transaction Report
Form 4
INGRAM ROBERT ALEXANDER
Director
Transactions
- Award
Common Stock
2022-09-16$2.62/sh+6,584$17,250→ 33,479 total
Footnotes (2)
- [F1]These shares were issued in accordance with the Issuer's Third Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer.
- [F2]The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on September 15, 2022.